influenza, antiviral, cap-dependent endonuclease inhibitor, TG-1000, phase III
Inflammatory bowel disease, colitis, psychiatric disorders, mental health, gut-brain axis
nausea and emesis, antiemetic prophylaxis, radiotherapy, chemotherapy, fosaprepitant, pilot randomised clinical trial
transjugular intrahepatic portosystemic shunt, overt hepatic encephalopathy, liver, spleen, 3D automatic assessment
overt hepatic encephalopathy prediction, transjugular intrahepatic portosystemic shunt, liver, spleen, portal venous system, muscle, fat, semi-supervised learning
nasopharyngeal carcinoma, apatinib, toripalimab, gemcitabine, recurrent/metastatic, genomic, transcriptional analyses